Two mutations affecting conserved residues in the Met receptor operate via different mechanisms
Open Access
- 2 March 2000
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 19 (10) , 1354-1361
- https://doi.org/10.1038/sj.onc.1203431
Abstract
We have investigated the mechanism by which two oncogenic mutations (M1268T and D1246H/N; Amino-acids are numbered according to Schmidt et al., 1999) affecting conserved residues in the catalytic domain of the Met receptor, activate its transforming potential. Both mutations were previously found in tumorigenic forms of the Ret and Kit receptors, respectively. The mutated residues are located either in the P+1 loop (M) or within the activation loop (A-loop) (D), which in a number of receptor tyrosine kinases harbors a pair of tandem tyrosines (Y1252-1253 in Met). Ligand-induced dimerization promotes their phosphorylation, and locks the A-loop into an open conformation. When unphosphorylated, the tandem tyrosines inhibit enzymatic activity by blocking the active site. Upon Y→F mutation of Y1252-1253, neither ligand binding nor Tpr-mediated dimerization can release this block. Here we show that the M1268T mutation partially rescues the kinase activity (and the transforming ability) of the Y1252-1253F Tpr-Met mutant, but is completely dependent on dimerization for its effect. In contrast, the two D1246H/N mutants strictly depend on Y1252-1253 for activity. Surprisingly, however, they constitutively activate the isolated cytoplasmic TK domain of Met (Cyto-Met). These data indicate that the two mutations operate via distinct mechanisms.Keywords
This publication has 41 references indexed in Scilit:
- Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signalingOncogene, 1999
- Signaling requirements for oncogenic forms of the Met tyrosine kinase receptorOncogene, 1998
- Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agentsOncogene, 1998
- “Invasive-growth” signaling by the Met/HGF receptor: The hereditary renal carcinoma connectionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
- The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro.Molecular Biology of the Cell, 1996
- Catalytic specificity of protein-tyrosine kinases is critical for selective signallingNature, 1995
- One gene—four syndromesNature, 1994
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- Expression and characterization of biologically active human hepatocyte growth factor (HGF) by insect cells infected with HGF-recombinant baculovirusBiochemistry, 1993
- The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.The Journal of cell biology, 1993